Fundraising Fox

Saliogen Therapeutics

Burlington, US · Founded 2020 · Delaware corporation

SalioGen Therapeutics was a genetic medicine company. The company is no longer operating.

Biotech

Founders & leadership

SN
Sukumar NagendranNamed on SEC filing
SS
Sean StalfortNamed on SEC filing
JH
Joseph HigginsNamed on SEC filing
RT
Raymond TabibiazarNamed on SEC filing

Reported raises · per SEC filings

Form D private placements

$152.2M disclosed across 2 rounds · 2021

▶$132.2MraisedApr 2022 · 24 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Sukumar NagendranDirector
  • Joseph HigginsExecutive Officer, Director
  • Craig GordonDirector
  • Raymond TabibiazarExecutive Officer, Director
  • Sean StalfortDirector
Offering amount
$132.2M
Amount sold
$132.2M
First sale
Nov 2021
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$20MraisedFeb 2021 · 3 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Sukumar NagendranDirector
  • Sean StalfortDirector
  • Joseph HigginsExecutive Officer, Director
  • Raymond TabibiazarExecutive Officer, Director
Offering amount
$20M
Amount sold
$20M
Placement agents
BTIG, LLC
First sale
Feb 2021
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 5

by search overlap
Biogen Idec11 shared keywordsBiogen is a biotechnology company founded in 1978 that focuses on breakthroughs in biology. The company serves patients through research and development in the life sciences industry.
Solugen10 shared keywordsSolugen develops a biomanufacturing platform using fermentation and bioprocessing technology to produce specialty chemicals at scale. The company serves customers in energy, chemicals, and related industries with cost-effective alternatives to traditional petrochemical-based manufacturing.
Soley9 shared keywordsSoley Therapeutics develops proprietary imaging, AI, and automation technology to analyze cellular responses to stress and drug exposure, enabling the discovery of novel medicines and therapeutic mechanisms.
Precigen9 shared keywordsPrecigen is a biopharmaceutical company developing gene and cell therapies, including PAPZIMEOS (zopapogene imadenovec-drba), an FDA-approved immunotherapy for adults with recurrent respiratory papillomatosis. The company focuses on immuno-oncology and immunotherapy treatments delivered via subcutaneous injection.
Wugen8 shared keywordsAllotera (formerly Wugen) develops allogeneic T-cell therapies. The company focuses on cell and gene therapy approaches for treating disease.

Companies competing with Saliogen Therapeutics for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Saliogen Therapeutics do?
SalioGen Therapeutics was a genetic medicine company. The company is no longer operating.
How much funding has Saliogen Therapeutics raised?
Saliogen Therapeutics has disclosed $152.2M raised across 2 rounds.
Where is Saliogen Therapeutics headquartered?
Saliogen Therapeutics is headquartered in Burlington, US.